HIGHLIGHTS
- who: Ray Wynford-Thomas from the Department of Neurology, University Hospital of Wales, Heath Park, Cardiff , XN, UK have published the research work: Amyotrophic lateral sclerosis: an update on treatments from clinical trials, in the Journal: (JOURNAL)
- future: Future trials therefore should consider the use of larger/more frequent doses to try and counter this although dose-escalation in these 2 participants failed to result in a treatment response. Future studies might be directed towards assessing the effect of higher doses of levosimendan in those with shorter disease duration and more rapidly progressive disease.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.